Literature DB >> 14627483

Gastric bypass in a Japanese man with Prader-Willi syndrome and morbid obesity.

Junji Kobayashi1, Masaaki Kodama, Kazuma Yamazaki, Okamichi Morikawa, Shunichi Murano, Norifumi Kawamata, Isao Kawamura.   

Abstract

BACKGROUND: In Prader-Willi syndrome (PrWS), marked obesity is the most serious and common complication, contributing significantly to morbidity and mortality. Because of the associated psychosocial difficulties, bariatric surgery appears to be the only effective treatment. CASE REPORT: A 30-year-old man with PrWS weighing 108 kg (BMI 50 kg/m2), underwent Roux-en-Y gastric bypass (RYGBP). 3 months before the RYGBP, he weighed 146 kg (BMI 68.5), partly because of heart failure. 18 months after RYGBP, he weighed 92.4 kg (BMI 43.3), with no postoperative complications. Moreover, he showed considerable increase in serum HDL-cholesterol levels with reciprocal reduction in LDL-cholesterol after the surgery.
CONCLUSION: RYGBP resulted in satisfactory weight loss and improvement in serum lipid profile in a Japanese morbidly obese patient with PrWS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627483     DOI: 10.1381/096089203322509453

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  6 in total

1.  Long-term experience with duodenal switch in adolescents.

Authors:  Picard Marceau; Simon Marceau; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Odette Lescelleur; Laurent Biertho; John G Kral
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

2.  Patients with Prader-Willi Syndrome (PWS) Underwent Bariatric Surgery Benefit more from High-Intensity Home Care.

Authors:  Songhao Hu; Biao Huang; Ken Loi; Xiaomei Chen; Qinyu Ding; Lan Luo; Cunchuan Wang; Wah Yang
Journal:  Obes Surg       Date:  2022-03-15       Impact factor: 3.479

Review 3.  Critical analysis of bariatric procedures in Prader-Willi syndrome.

Authors:  A O Scheimann; M G Butler; L Gourash; C Cuffari; W Klish
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-01       Impact factor: 2.839

4.  BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits.

Authors:  F De Peppo; G Di Giorgio; M Germani; E Ceriati; P Marchetti; C Galli; M G Ubertini; S Spera; G Ferrante; M Cuttini; M Cappa; G Castelli Gattinara; M Rivosecchi; A Crinò
Journal:  Obes Surg       Date:  2008-05-01       Impact factor: 4.129

5.  Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese.

Authors:  Anthony K W Fong; Simon K H Wong; Candice C H Lam; Enders K W Ng
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

6.  The usefulness of biliopancreatic diversion/Scopinaro operation in treatment of patients with Prader-Willi syndrome.

Authors:  Maciej Michalik; Agata Frask; Pawel Lech; Michal Zdrojewski; Anna Doboszynska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-03-10       Impact factor: 1.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.